Inventiva - Public Comps and Valuation Multiples

Inventiva Overview

About Inventiva

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Founded

2011

HQ

Employees

119

Website

inventivapharma.com

Sectors

Biopharmaceuticals
Drug Development & Therapeutics
BioTech

Financials

LTM Revenue $10.2M

LTM EBITDA -$130M

EV

$499M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Inventiva Financials

As of September 2025, Inventiva reported last 12-month revenue of $10.2M and EBITDA of -$130M.

In the same period, Inventiva generated $6.1M in LTM gross profit and -$214M in net income.

See Inventiva valuation multiples based on analyst estimates

Inventiva P&L

In the most recent fiscal year, Inventiva reported revenue of $10.6M and EBITDA of -$193M.

Inventiva expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Inventiva valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$10.2M	XXX	$10.6M	XXX	XXX	XXX
Gross Profit	$6.1M	XXX	n/a	XXX	XXX	XXX
Gross Margin	60%	XXX	n/a	XXX	XXX	XXX
EBITDA	-$130M	XXX	-$193M	XXX	XXX	XXX
EBITDA Margin	-1275%	XXX	-1810%	XXX	XXX	XXX
EBIT	-$126M	XXX	-$109M	XXX	XXX	XXX
EBIT Margin	-1238%	XXX	-1022%	XXX	XXX	XXX
Net Profit	-$214M	XXX	-$213M	XXX	XXX	XXX
Net Margin	-2103%	XXX	-2003%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Inventiva including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $10.2M. EBITDA for the last twelve months was -$130M. In the most recent fiscal year, Inventiva achieved $10.6M in revenue and -$193M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$10.2M	Analyst estimates available to subscribers	$10.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$6.1M	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	60.5% gross margin	Analyst estimates available to subscribers	NaN% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	-$130M	Analyst estimates available to subscribers	-$193M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	-1275.1% EBITDA margin	Analyst estimates available to subscribers	-1810.4% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	-$126M	Analyst estimates available to subscribers	-$109M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	-1238.3% EBIT margin	Analyst estimates available to subscribers	-1021.8% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$214M	Analyst estimates available to subscribers	-$213M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-2102.6% net profit margin	Analyst estimates available to subscribers	-2002.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Inventiva

This financial data table provides comprehensive performance metrics for Inventiva, a company based in France. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Inventiva generated $10.2M in revenue over the last twelve months.
The company achieved -$130M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $6.1M.
Net income over the last twelve months reached -$214M.

Fiscal Year Performance

In the most recent fiscal year, Inventiva reported $10.6M in total revenue.
Fiscal year EBITDA was -$193M.
The company maintained a gross profit margin of NaN% in the most recent fiscal year.
EBITDA margin for the fiscal year was -1810.4%.
Net profit margin reached -2002.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Inventiva. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Inventiva Stock Performance

Inventiva has current market cap of EUR 521M (or $602M), and EV of EUR 431M (or $499M).

Market Cap Evolution

Inventiva Stock Data

As of October 17, 2025, Inventiva's stock price is EUR 4 (or $4).

See Inventiva trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$499M	$602M	XXX	XXX	XXX	XXX	$-2.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Inventiva Valuation Multiples

Inventiva's trades at 46.9x EV/Revenue multiple, and -2.6x EV/EBITDA.

See valuation multiples for Inventiva and 15K+ public comps

Inventiva Financial Valuation Multiples

As of October 17, 2025, Inventiva has market cap of $602M and EV of $499M.

Equity research analysts estimate Inventiva's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Inventiva has a P/E ratio of -2.8x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$602M	XXX	$602M	XXX	XXX	XXX
EV (current)	$499M	XXX	$499M	XXX	XXX	XXX
EV/Revenue	49.1x	XXX	46.9x	XXX	XXX	XXX
EV/EBITDA	-3.9x	XXX	-2.6x	XXX	XXX	XXX
EV/EBIT	-4.0x	XXX	-4.6x	XXX	XXX	XXX
EV/Gross Profit	81.2x	XXX	n/a	XXX	XXX	XXX
P/E	-2.8x	XXX	-2.8x	XXX	XXX	XXX
EV/FCF	-5.8x	XXX	-5.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Inventiva Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Inventiva Margins & Growth Rates

Inventiva's last 12 month revenue growth is -44%

Inventiva's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $1.0M for the same period.

Inventiva's rule of 40 is -628% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Inventiva's rule of X is -1385% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Inventiva and other 15K+ public comps

Inventiva Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	-44%	XXX	-34%	XXX	XXX	XXX
EBITDA Margin	-1275%	XXX	-1810%	XXX	XXX	XXX
EBITDA Growth	5%	XXX	n/a	XXX	XXX	XXX
Rule of 40	-628%	XXX	-1854%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	-1385%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$1.0M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	18%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	988%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	1122%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial